Luminescence imaging technology developer Lightpoint Medical has received a CE Mark for Sensei, the first robotic gamma probe to be commercially available in Europe.
Lightpoint Medical's Sensei device. Image courtesy of Lightpoint.Sensei is designed for the intraoperative detection of sentinel lymph nodes and cancer metastasis throughout the lymphatic system. The device aims to provide more precise, targeted cancer surgery and is applicable for major cancer types, including lung, colorectal, stomach, gynecological, and prostate cancer.
